125 related articles for article (PubMed ID: 28677540)
1. Generation of non-transgenic iPS cells from human cord blood CD34
Haase A; Göhring G; Martin U
Stem Cell Res; 2017 May; 21():71-73. PubMed ID: 28677540
[TBL] [Abstract][Full Text] [Related]
2. Virus-free and oncogene-free induced pluripotent stem cell reprogramming in cord blood and peripheral blood in patients with lung disease.
Kamath A; Ternes S; McGowan S; Moy AB
Regen Med; 2018 Dec; 13(8):889-915. PubMed ID: 30488785
[TBL] [Abstract][Full Text] [Related]
3. [Efficient reprogramming of human cord blood CD34(+) cells for formation of induced pluripotent stem cells with non-integrating plasmid system].
Zhang QE; Liu SP; Liu YF; Zhang HY; Yuan WP; Chen GB; Li YX; Xu J
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2013 Jun; 21(3):728-34. PubMed ID: 23815931
[TBL] [Abstract][Full Text] [Related]
4. Generation of human iPSCs from fetal prostate fibroblasts HPrF.
Kahounová Z; Slabáková E; Binó L; Remšík J; Fedr R; Bouchal J; Vrtěl R; Jurečková L; Porokh V; Páralová D; Hampl A; Souček K
Stem Cell Res; 2019 Mar; 35():101405. PubMed ID: 30776675
[TBL] [Abstract][Full Text] [Related]
5. Reprogramming human B cells into induced pluripotent stem cells and its enhancement by C/EBPα.
Bueno C; Sardina JL; Di Stefano B; Romero-Moya D; Muñoz-López A; Ariza L; Chillón MC; Balanzategui A; Castaño J; Herreros A; Fraga MF; Fernández A; Granada I; Quintana-Bustamante O; Segovia JC; Nishimura K; Ohtaka M; Nakanishi M; Graf T; Menendez P
Leukemia; 2016 Mar; 30(3):674-82. PubMed ID: 26500142
[TBL] [Abstract][Full Text] [Related]
6. GMP-compatible manufacturing of three iPS cell lines from human peripheral blood.
Haase A; Glienke W; Engels L; Göhring G; Esser R; Arseniev L; Martin U
Stem Cell Res; 2019 Mar; 35():101394. PubMed ID: 30772682
[TBL] [Abstract][Full Text] [Related]
7. Development and characterization of human iPSC line NCCSi004-A from umbilical cord blood (UCB) derived CD34
Fernandes S; Tembe S; Singh S; Vardhan S; Nair V; Kale V; Limaye L
Stem Cell Res; 2019 Mar; 35():101392. PubMed ID: 30711803
[TBL] [Abstract][Full Text] [Related]
8. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells.
Okita K; Yamakawa T; Matsumura Y; Sato Y; Amano N; Watanabe A; Goshima N; Yamanaka S
Stem Cells; 2013 Mar; 31(3):458-66. PubMed ID: 23193063
[TBL] [Abstract][Full Text] [Related]
9. Generation and characterization of human iPSC line from CD34
Fernandes S; Talwadekar M; Agarwal R; Nair V; Kale V; Limaye L
Stem Cell Res; 2017 Jan; 18():60-63. PubMed ID: 28395807
[TBL] [Abstract][Full Text] [Related]
10. Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells.
Gao X; Yourick JJ; Sprando RL
Stem Cell Res; 2017 Dec; 25():202-212. PubMed ID: 29156376
[TBL] [Abstract][Full Text] [Related]
11. Derivation of human iPSC line NCCSi002-A from umbilical cord blood (UCB) CD34+cells of donor from Indian ethnicity.
Fernandes S; Shinde P; Khan N; Singh S; Vardhan S; Nair V; Kale V; Limaye L
Stem Cell Res; 2018 Jan; 26():80-83. PubMed ID: 29268156
[TBL] [Abstract][Full Text] [Related]
12. Efficient generation of transgene-free human induced pluripotent stem cells (iPSCs) by temperature-sensitive Sendai virus vectors.
Ban H; Nishishita N; Fusaki N; Tabata T; Saeki K; Shikamura M; Takada N; Inoue M; Hasegawa M; Kawamata S; Nishikawa S
Proc Natl Acad Sci U S A; 2011 Aug; 108(34):14234-9. PubMed ID: 21821793
[TBL] [Abstract][Full Text] [Related]
13. Generation of human induced pluripotent stem cells from cord blood cells.
Nishishita N; Takenaka C; Fusaki N; Kawamata S
J Stem Cells; 2011; 6(3):101-8. PubMed ID: 23264996
[TBL] [Abstract][Full Text] [Related]
14. Sendai Virus-Based Reprogramming of Mesenchymal Stromal/Stem Cells from Umbilical Cord Wharton's Jelly into Induced Pluripotent Stem Cells.
Miere C; Devito L; Ilic D
Methods Mol Biol; 2016; 1357():33-44. PubMed ID: 26246353
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells with CytoTune, a non-integrating Sendai virus.
Lieu PT; Fontes A; Vemuri MC; Macarthur CC
Methods Mol Biol; 2013; 997():45-56. PubMed ID: 23546747
[TBL] [Abstract][Full Text] [Related]
16. Tumor-Free Transplantation of Patient-Derived Induced Pluripotent Stem Cell Progeny for Customized Islet Regeneration.
El Khatib MM; Ohmine S; Jacobus EJ; Tonne JM; Morsy SG; Holditch SJ; Schreiber CA; Uetsuka K; Fusaki N; Wigle DA; Terzic A; Kudva YC; Ikeda Y
Stem Cells Transl Med; 2016 May; 5(5):694-702. PubMed ID: 26987352
[TBL] [Abstract][Full Text] [Related]
17. Generation of two transgene-free human iPSC lines from CD133
Arellano-Viera E; Zabaleta L; Castaño J; Azkona G; Carvajal-Vergara X; Giorgetti A
Stem Cell Res; 2019 Apr; 36():101410. PubMed ID: 30878013
[TBL] [Abstract][Full Text] [Related]
18. Effects of Integrating and Non-Integrating Reprogramming Methods on Copy Number Variation and Genomic Stability of Human Induced Pluripotent Stem Cells.
Kang X; Yu Q; Huang Y; Song B; Chen Y; Gao X; He W; Sun X; Fan Y
PLoS One; 2015; 10(7):e0131128. PubMed ID: 26131765
[TBL] [Abstract][Full Text] [Related]
19. Human-induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders.
Ye Z; Zhan H; Mali P; Dowey S; Williams DM; Jang YY; Dang CV; Spivak JL; Moliterno AR; Cheng L
Blood; 2009 Dec; 114(27):5473-80. PubMed ID: 19797525
[TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of human umbilical cord blood-derived induced pluripotent stem cells (KRIBBi005-A).
Koh H; Zhen X; Kim J; Ha HY; Lee JH
Stem Cell Res; 2022 Apr; 60():102674. PubMed ID: 35085946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
